Comparative Use of Napsin A and Glypican 3 to Distinguish Endometrial Clear Cell from Serous and Endometrioid Carcinomas
Eirwen M. Miller(Albert Einstein College of Medicine), Akiva P. Novetsky(Albert Einstein College of Medicine), Joan Tymon‐Rosario(Yale University), Bryan Harmon(Albert Einstein College of Medicine), Jaya Sunkara(Albert Einstein College of Medicine), Rouzan G. Karabakhtsian(Albert Einstein College of Medicine)
Cited by 5
Related Papers
Triple-Negative Breast Carcinoma
|American Journal of Clinical Pathology|2014|168
Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts
|Cancer Cell|2022|88
Determination of Coordinated Maintenance Scheduling Frequencies for a Group of Machines
|A I I E Transactions|1979|35
Use of risk-based cervical screening programs in resource-limited settings
|Cancer Epidemiology|2023|30